Localization projects experience

POLYSAN has been developing the contract manufacturing business line since 2015 and has already built a partnership with lead global pharmaceutical companies like Bayer, Pfizer и STADA. Main contract manufacturing directions: tablets, solution for infusions, intravenous and intramuscular solutions.

POLYSAN localizes four original DPs within the joint project with Bayer.

Total product output will amount to more than 2 mio packs/year upon completion of the technological transfer stage.

POLYSAN’s contract manufacturing projects brief

2012

Signing of the antioxidant DP localization agreement (STADA)

2013

Commercial production of the antioxidant DP (STADA)

2014

Studying DPs localization aspects (requested by Pfizer and Bayer)

2015

Signing of Strategic partnership agreement (Bayer) and Contract manufacturing agreements with Pfizer (tablets) and Bayer (contrast media)

2016

Signing of the coagulant DP contract manufacturing agreement (Bayer)

2017

Signing of the antibacterial DP contract manufacturing agreement (STADA)

2018

Launch of X-ray contrast media commercial production (Bayer)

2019

Launch of contrast media (Bayer), tablets (Pfizer) and the antibacterial DP (STADA) commercial production

Key commercial indicators of the projects

- localization projects production volume – app. 15% of POLYSAN’s own DP production volumes;
- average time limits for DP localization project – 3.5 years;
- Localized product sales volumes in Russia – more than 10 billion RUB.